The Biofisika Institute (CSIC, EHU) and several Basque institutions are studying CTNNB1 syndrome, a rare disease linked to ...
News-Medical.Net on MSN
Study aims to understand molecular origins of CTNNB1 neurodevelopmental syndrome
On the occasion of Rare Disease Day, the Biofisika Institute (CSIC, EHU) presents the progress of a project aimed at understanding the molecular origin of CTNNB1 neurodevelopmental syndrome, a rare ...
In a development that could transform how scientists study cancer, neurodegeneration and inflammation, researchers have invented a new sensor that enables MRI machines to visualize molecular activity ...
The International Society for Stem Cell Research (ISSCR) proudly announces Kyle M. Loh, Stanford University School of Medicine, as the recipient of the 2026 ISSCR Early Career Impact Award, ...
Researchers developed a protein-based sensor that lets MRI machines visualize molecular activity inside cells, potentially transforming study of cancer and disease.
Growing neurons rely on chemical cues to find their targets, but new research shows that the brain’s physical properties help shape those signals. Scientists discovered that tissue stiffness can ...
Advanced 3D reconstructions of the comb jelly’s aboral organ reveal a sensory system far more complex than scientists expected. The organ contains a wide variety of specialized cells and is closely ...
6 core challenges that researchers must consider as the race to create models that are ever closer to real human embryos heats up.
Why do so many workplace frustrations in veterinary medicine feel hard to explain? Building on last week’s episode of The Resilient Vet: Mind and Body Strategies for Success, hosts Aaron Shaw, OTR/L, ...
Author(s)Leilani Alvarez, DVM, DACVSMR, CVA, CCRT, Abi Bautista-Alejandre, Assistant Editor Collagen-supporting ingredients and antioxidants may help address the broader “joint organ” in dogs with ...
Blueprint Medicines, a Sanofi company, today announced AYVAKIT® (avapritinib) data showing clinically meaningful outcomes and ...
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results